Browsing by Author "Curescu, M. G."

Now showing 1 - 2 of 2

Anti-hdv-igm as a marker of disease activity in hepatitis delta
(Elsevier Science Bv, 2013-04-01) Wranke, A.; Yurdaydin, C.; Heidrich, B.; Caruntu, F. A.; Curescu, M. G.; Yalçin, K.; Zeuzem, S.; Erhardt, A.; Lueth, S.; Papatheodoridis, G. V.; Bremer, B.; Stift, J.; Grabowski, J.; Kirschner, J.; Port, K.; Cornberg, M.; Falk, C.; Dienes, H. P.; Hardtke, S.; Manns, M. P.; Wedemeyer, H.; HIDIT-2 Study Grp; Gurel, S.; GÜREL, SELİM; Bursa Uludağ Üniversitesi/Tıp Fakültesi; HLH-8209-2023
Prolonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent hdv rna relapse after treatment: The hidit-2 study
(Elsevier, 2014-04-01) Wedemeyer, H.; Yurdaydin, C.; Ernst, S.; Caruntu, F. A.; Curescu, M. G.; Yalcin, K.; Akarca, U. S.; Gürel, Selim; Zeuzem, S.; Erhardt, A.; Lueth, S.; Papatheodoridis, G. V.; Keskin, O.; Port, K.; Radu, M.; Celen, M. K.; Ildeman, R.; Stift, J.; Heidrich, B.; Mederacke, I.; Hardtke, S.; Koch, A.; Dienes, H. P.; Manns, M. P.; HIDIT-2 Study Grp; GÜREL, SELİM; Uludağ Üniversitesi/Tıp Fakültesi; HLH-8209-2023